Axelyf
Entity
Description
  • Value proposition

    Developing next-generation lipid nanoparticle delivery systems to unlock the potential of RNA therapeutics

    Axelyf was founded in Iceland in 2022 with the goal of harnessing health benefits of natural molecules through chemistry and delivery engineering.

  • Axelyf, Inc.

    Building Next-Generation RNA-LNP Therapeutics: experienced drug developers with distinctive technologies - for partners, programs and patients

    • https://www.axelyf.com/
Catalyst interactions
Catalyst Type Tweets Articles
No interactions
Social network dynamics
Similar entities
BETA
Last news
Show all articles